{
  "zip": "98021",
  "sector": "Healthcare",
  "fullTimeEmployees": 8,
  "longBusinessSummary": "Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.",
  "city": "Bothell",
  "phone": "425-402-8400",
  "state": "WA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.helixbiomedix.com",
  "maxAge": 1,
  "address1": "22121-17th Avenue SE",
  "fax": "425-806-2999",
  "industry": "Biotechnology",
  "address2": "Suite 112",
  "previousClose": 24.8,
  "regularMarketOpen": 24.8,
  "twoHundredDayAverage": 25.148705,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 24.8,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 24.8,
  "fiftyDayAverage": 24.8,
  "trailingAnnualDividendRate": null,
  "open": 24.8,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.026785,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 24.8,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 48,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 7125883,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 22,
  "priceToSalesTrailing12Months": 3.4492624,
  "dayLow": 24.8,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 48,
  "fiftyTwoWeekHigh": 42,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 24.8,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 24.8,
  "exchange": "PNK",
  "shortName": "HELIX BIOMEDIX INC",
  "longName": "Helix BioMedix, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "HXBM",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_413088",
  "uuid": "e29c0d63-518a-3007-94b5-24c2392e8e39",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 1.885,
  "beta3Year": null,
  "profitMargins": -1.25062,
  "enterpriseToEbitda": -1.672,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 165718,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 6.939,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1325289600,
  "heldPercentInstitutions": null,
  "netIncomeToCommon": -2583671,
  "trailingEps": -15.589,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 3.5740018,
  "heldPercentInsiders": null,
  "nextFiscalYearEnd": 1388448000,
  "mostRecentQuarter": 1348963200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 3893669,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1357171200,
  "lastSplitFactor": "1:300",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 24.8,
  "logo_url": "https://logo.clearbit.com/helixbiomedix.com"
}